TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Go back to TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
TG THERAP (NASDAQ: TGTX) Delayed: 54.40 --0 (-0%)
Previous Close $54.40    52 Week High $14.87 
Open $54.40    52 Week Low $4.90 
Day High $54.40    P/E N/A 
Day Low $54.40    EPS $-0.67 
Volume 967